chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Below is the email sent to my PCP via messaging system.  Sent:6/28/2021 5:24 AM CDT To: MD Subject:Question About Non-Urgent Medical Matter  Good morning Dr.,  I wanted to inquire if it is still normal that I am experiencing pain at the injection site since receiving the pneumococcal vaccine on 6/17/2021. The pain can be described as a shooting pain that radiates to the rotator cuff. It's also painful to lie on my arm or to put my arm directly straight out. I am relatively active, especially being outside and since receiving the vaccine I feel that my range of motion is hindered. I have not felt this on my left arm where I received the tetanus, only the right one. Thank you Ma'am and I look forward to hearing from you.   Progress Notes from, FNP at 7/2/2021 11:01 AM: Arm pain 6/7/2021  received 2 vaccines. Tdap Lt arm  PCV on Rt . Rt arm is still painful.   Pain is positional- with movement up or backward. Pain radiates from injection site which  Is upper deltoid as per pt into mid upper arm. Initial redness and pain resolved after a few days but positional, shooting pain continues.  Taking Motrin 800mg about daily and using heat with sub optimal relief.  Musculoskeletal:     Comments: Rt upper arm. No visible site of injection. Pt can pinpoint site as source of pain in upper deltoid below humeral head.   No redness, swelling Exquisite tenderness to light touch. In area of about 6 cm around injection site.    FROM of RUE with pain on full abduction.
Around 4 or 5 in the pm patient started to have itching at site. Apply hydrocortisone cream to area then noticed swelling around 6 pm upon awakening swelling had spread down to wrist. Patient went to urgent care was told maybe infected or perhaps reaction.
Patient's daughter came in the day after mom got vaccine and stated that her mom was very ill and bed ridden.  She said she was not feeling well earlier in the week  and was having diarrhea.  All she said is her 91 yo mom was very sick because of the vaccine and was bed ridden and she was very worried about her.
Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 24-FEB-2015 and 24-APR-2015, the patient was respectively vaccinated with improperly stored GARDASIL (lot # K003520 with expiration date of 20-NOV-2016; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
sore arm, sore shoulder, tiredness, couldn't eat, swollen arm like egg, took advil, stabbing pain in arm, tinging fingers,itching
Extreme Fatigue, Dizziness, diarrhea, nausea, right eye excessive twitching, with heavy eyelid.  Muscle aches.  Headache. Confusion.   These lasted for most of Saturday into Sunday.  Monday  - still ill.   Today  the following symptoms still  persist: fatigue, eye twitching with heavy eyelid, headache,
Continuous sharp pain in right elbow/constant sharp pain in right elbow joint; pain was in entire right arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 12Mar2021 (Lot number: EN6199) at the age of 41 years as dose 1, single and administered in arm right, administration date 09Apr2021 (Lot number: EW0151) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: ARTHRALGIA (disability) with onset 13Mar2021, outcome "recovered with sequelae" (2021), described as "Continuous sharp pain in right elbow/constant sharp pain in right elbow joint"; PAIN IN EXTREMITY (disability) with onset 13Mar2021, outcome "recovered with sequelae" (2021), described as "pain was in entire right arm". The events "continuous sharp pain in right elbow/constant sharp pain in right elbow joint" and "pain was in entire right arm" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: magnetic resonance imaging: unknown results; x-ray: unknown results. Therapeutic measures were taken as a result of arthralgia, pain in extremity. Clinical course: No known allergies, The patient experienced continuous sharp pain in right elbow. For the first day, the pain was in entire right arm due to the shot but slowly started turning into constant sharp pain in right elbow joint. Pain was slowly decreasing each week, but then came back again after 2nd shot. The pain lasted for several months and slowly started fading around 4 months after the 2nd dose shot. Treatment included pain and anti-inflammation meds post x-ray/MRI. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive other medications within 2 weeks of vaccination. Prior to vaccination, the was not patient diagnosed with COVID-19.  Since the vaccination, the patient has not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.
increased risk of exposure to COVID-19 virus  Generalized body aches  Fatigue, unspecified type
fever. chills. headache. upset stomach. sore left arm. body aches throughout.  800 mg ibuprofen. meds helped relieve symptoms.  all symptoms returned 7 hours later.   800 mg ibuprofen 2nd time.  helped relieve symptoms.  all symptoms returned 7 hours later but not as severe. 800 mg 3rd time.   currently waiting for relief.
After a few days post vaccine, I began to feel a sharp pain on the right side of my chest. Every time I took a deep breath or moved my head I would feel a sharp pain on the right side. I message my provider on the 31st. Shortly after went to the doctor's office and after running a few tests and blood work they did not see anything abnormal, chest x-ray showed nothing abnormal either. Lingering pain for a while, however the pain went away after about two weeks and for a few months after if I took a really deep breath it then will come back.
This spontaneous report as received from a nurse practitioner refers to a 19 month old patient of unknown gender. No information on patient's medical history or concurrent conditions was provided. On 19-DEC-2014, the patient was vaccinated with a dose of PEDVAX HIB lot # K008874 (dose, strength, route of administration and expiration date were not reported) which had temperature excursion (incorrect product storage). No information on patient's concomitant medication was provided. This is one of several reports from the same reporter. Additional information has been requested.
Sever insomnia since 1/8. Cold/pins and needles feeling on right extremities since 1/9
no appetite, stayed in bed, headache, body aches, fever 104-105 F which responded to acetaminophen, pt  looked ill. Acetaminophen was given as needed and then required to give it every 4-6 hr to keep fever under control. after 3 days symptoms started to resolve.
Seizure 3-4 days after injection.  Patient currently admitted to hospital for observation.
Hot; Injection site itching; Redness; Swelling; Sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (Sore) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 075L2(or Z)0A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Sulfonamide allergy, Parkinson's disease, Diabetes, Blood pressure high and Hypercholesterolemia. Concomitant products included DULAGLUTIDE (TRULICITY), LIDOCAINE, PRILOCAINE (LIDOPIN [LIDOCAINE;PRILOCAINE]), METOPROLOL, CLONAZEPAM and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Hot), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (Sore). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Hot), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (Sore) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-197502 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Follow up received on 2/JUN/2021updated Event outcome recovered.
Pt received Tdap on 4/1/11 & dev'd pain at site: (L) deltoid, radiating down left arm. Pain was very severe initially and also caused a decrease of ROM, pt is unable to lift (L) arm above head without pain. Pt has tried ALEVE & ice w/out any improvement. Pain has improved from the severity of it initially.
Mild case of chicken pox after getting the varicella vaccination which lasted 2 weeks. Patient has bumps on the head, face, arms, legs and belly.  Also mild rash outbreak for 1-2 days from MMR vaccination.
body aches so badly; body temperature ran over 100 Degree; Shivering; Headache; Not feeling well; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 30Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Covid-19" (unspecified if ongoing), notes: I had the COVID three years ago. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine janssen (Dose: 3rd (1st booster), Manufacturer: Johnson & Johnson), for COVID-19 immunization; Covid-19 vaccine (Dose: 2, Unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose: 1, Unknown manufacturer), for COVID-19 immunization. The following information was reported: PAIN (non-serious), outcome "unknown", described as "body aches so badly"; PYREXIA (non-serious), outcome "unknown", described as "body temperature ran over 100 Degree"; CHILLS (non-serious), outcome "unknown", described as "Shivering"; HEADACHE (non-serious), outcome "unknown"; MALAISE (non-serious), outcome "unknown", described as "Not feeling well". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: The patient had the Pfizer Booster yesterday and had the COVID three years ago, now and  had just a very mild case that lasted for it, so about 4 hours and then the patient lost my taste and smell, with just same sign as the patient had the COVID that was very mild, so yesterday when the patient had Pfizer COVID-19 Vaccine, the patient was feeling fine yesterday and the body aches so badly and body temperature ran over 100 Degree and the patient was Shivering and had headache, so just wanted to know is that listed as possible side effects or should the patient be concerned about my health or not. The reported that it had had COVID and later then it had Booster (COVID Vaccine) and for its second Booster the patient chose not to get the because the patient understood to have Pfizer about 4 months, so it had if it is good to have for mix (vaccination), so the patient chose Pfizer (COVID-19 Vaccine) yesterday. The patient asked to put its check by continue to get the Booster would have the same side effect just to the same pattern or not.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a healthcare worker referring to a 4 year old patient of unknown gender. No relevant medical history or concurrent conditions were reported. On 15-JUN-2015 the patient was vaccinated with 0.5ml dose of VARIVAX (unspecified lot# but could included lot # K026386, expiration date 15-DEC-2016 or lot# K020757, 31-OCT-2016) which had been exposed to temperatures outside of the recommended range, subcutaneously. No adverse effect had been reported. This is one of several reports received from the same reporter. Additional information has been requested.
Devel skin rash the following day p/vax was administered; referred to dermatologist & allergist;
Rash at injection site. Rash down both sides of torso.  eyes ichy.
Chest pain, short of breath, fatigue, sore throat, diarrhea, feeling faint.  I did not connect this to the vaccine until I heard on the news today, 05/24/2021.  I am an active person but wasn't able to exercise and when I did I felt sick.  On a hike, I felt like I was going to faint and throw up because my heart was beating so hard and fast.  I regularly hike and have never had these symptoms before.  I am back to doing cardio and don't have any of the symptoms 7-1/2 weeks later.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Headache. Concomitant products included PARACETAMOL (TYLENOL) for Headache, OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 26-Mar-2021, PAIN IN EXTREMITY (Sore arm) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Other relevant concomitant medications included, birth control medication was reported.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-090177 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090177:
Information was received from an Immunization nurse on behalf of a patient on 10JUL2013, 09AUG2013, 21AUG-2013, 04SEP2013 and 21OCT2013. On 14MAY2013, a 46 year old male received dose #4 of BIOTHRAX (lot FAV429) intramuscularly in the left deltoid. On that same day he began to experience persistent pain in the area of the injection site. At three days post immunization the pain became "less intense", but has persisted without change in intensity from that point. On 10JUL2013, the patient returned to the Immunization clinic to report the persistent pain. He was referred to an occupational health clinic for evaluation. On 12JUL2013, was seen by a physician. On exam, his left shoulder area was tender. He was prescribed MOBIC for the pain and physical therapy with home exercises. 30JUL2013 - MRI shoulder left w/o contrast indicated 1. Partial thickness undersurface tear of the insertion of the mild to superior fibers of the subscapularis, involving up to 50% of the tendon thickness. 2. Infraspinatus tendinosis. 3. Small superior to posterosuperior glenoid labral tear. The subject completed physical therapy with home exercises program and MOBIC therapy as prescribed. He reports that he was fully recovered on 03SEP2013.
Information has been received from the center (VAERS ID 178149) concerning a 2 month old male who on 12/13/01 was vaccinated IM in the right leg with a first dose of Comvax (640503/0933L). Concomitant vaccine therapy included a first dose SQ in the left leg of poliovirus vaccine (U0344), Tripedia (U03400A) and a first dose of IM in the right leg Prevnar (484145). Other concomitant medication included Zantac and gentian violet. On 12/13/01 the pt was taken to the ER for a febrile illness. He was hospitalized and diagnosed with sepsis. From additional correspondence received at manufacturer on 6/21/02 it was reported: A follow-up call was placed to manufacturer (U2002-00103 originated from manufacturer) to determine if these two cases (U200200103 and U200200151) are duplicates. Manufacturer is unable to confirm if they are duplicates at this time. More info is expected. Follow-up #2 (latest received date 1/14/01): During internal review of this case, it was determined that case U200200103 is a duplicate. Case U200200151 will be referred to as the report of reference. No new info was obtained. The lot number for Tripedia was corrected to U03400A as per the source documentation.  Follow up on 07/07/2003: "From additional information received on 06/24/2003 through a telephone conversation with the reporter from the manufacturer, it was reported that they had not received any new information for this case, nor is any anticipated, therefore this case will be closed."
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The patient had no known allergies. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: COVID rebound after 4 days being negative; Unknown results, notes: COVID rebound after 4 days being negative. Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient received Paxlovid from 05Jul2022 to 08Jul2022 for COVID-19 treatment. The patient had COVID rebound after 4 days being negative. Runny nose and persistent cold symptoms, no fever and no sore throat.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Mild Rash all over appear 10 days after vaccine; This is a spontaneous report from a contactable nurse (patient). A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Solution for injection lot no. EH9899, expiry date: not reported), intramuscular on 08Jan2021 08:30 at a single dose (first dose) on left arm for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient previously took cipro [ciprofloxacin hydrochloride] which she had known allergies.  The patient experienced mild rash all over appear 10 days after vaccine (18Jan2021).  The patient has no COVID prior vaccination and has not tested post vaccination. The COVID vaccine was administered in a hospital. She had no other vaccines received in four weeks and no treatment was received in response to the adverse event. The outcome of the event was not recovered.
Varicella vaccine breakthrough. Seen in office on 06/21/2006, with varicella. Had five lesions. No fever.
Pain, Redness, Swelling at injection site, Headache, muscle pain, chills, joint pain, fever, nausea, fatigue
HPI Patient is 83 years old with past medical history of asthma, congestive heart failure, aortic valve replacement, hyperlipidemia, interstitial lung disease, rheumatoid arthritis presented to the hospital with a chief complaint of shortness of breath, and diarrhea associated with generalized weakness and fatigue.  Patient was found to have COVID yesterday morning.  She was initiated on Paxlovid by her PCP.  Patient recently had a total hip replacement.  She has not been moving much and stayed in bed and subsequently developed decub ulcer in the back.  She currently has a wound VAC.  Patient has not been eating or drinking much.  She was initiated on prednisone daily which she has been taking.  When seen, patient was resting in bed comfortably.  Otherwise patient has no fever, chills, chest pain, abdominal pain, nausea, vomiting, difficulty with urination, dysuria.  Admits to dry cough.   In the ED, patient was given a bolus normal saline 500 cc.HPI per admitting nocturnist     Clinical Summary   Clinical course Include/ Problem list COVID infection Dyspnea Hx Interstitial lung disease and Bronchiectasis HX Asthma and COPD COPD with chronic respiratory failure - Home Covid test positive on 8/11. - Continue Dexamethasone - Patient received 2 doses of Paxlovid OP prior to arrival - She is at baseline oxygen 2-3 liters - Blood cultures pending - Pulmonology consult, recommendations appreciated - Continue albuterol, incentive spirometer and supportive care - Procal 0.13 will hold off on antibiotics as this is likely viral  - Special isolation     Leukopenia likely 2/2 Covid/resolved - CBC in AM, will monitor Weakness General weakness with reduced mobility, POA - PT and social consult, PT recommended continued therapy at DC - Family and patient are interested in SNF for therapy at discharge     Diarrhea rule out C. Difficile vs Side Effect Paxlovid - Cdiff and Stool PCR pending - No BM since arrival to hospital. Diarrhea started after taking Paxlovid at home.      Elevated blood pressureno prior history of hypertension - BP improved from admission currently 119/77 - Continue Amlodipine, will add hold parameters  Continue Hydralazine PRN SBP greater than 160 - May need antihypertensive at DC, however will monitor as hypertension could be 2/2 acute infection/illness Hydralazine was given scheduled every 8 hours during patient's admission.  Patient be discharged with hydralazine and a blood pressure kit with instructions to hold if systolic blood pressures less than 110.    Decubitus ulcer stage 4, POA - Wound Vac in place - Consult wound care     Anxiety/depression - Continue Home Lexapro - Will add Hydroxyzine PRN anxiety     CHFcurrently compensated Aortic Stenosis S/p TAVR in 2018 - Echocardiogram ordered and pending - Previous Echo from April 2023 shows EF 55-60%, Severely dilated left atrium. TAVR well seated and function normal. - Cardiology consulted - Continue home ASA and betablocker
A few hours after receiving the vaccine, I became very achy all over my body, suddenly tired, and sweating even though I was cold. It felt as though I had a bad case of the flu, though my only symptoms were achy bones and muscles, fever, and headache. I had a fever ranging from 99 to 101 for a solid 24 hours and could barely move.
Lowe grade fever, chills, hot flashes, then lack of energy, nausea, diarrhea, skin reaction spots, lips swelling, wheezing
glands under arms  and sides of neck started swelling on third day after vaccine, lasted for over a week. Ten days after vaccine,  on July 23, a red rash was noticed near the injection sight. The rash was red and tripled in size in two days and the glands under that arm were tender. On July 26, the rash  and redness started to fade. Some redness still remains a week later. Other symptoms from the vaccine include fatigue and some diarrhea. My arm is still sore at the injection site at this time, 20 days from receiving the vaccine on July 13.  I contacted Dr. office on July 23 when rash appeared and was told to  watch the rash and call them if it was still there after the weekend.